Nabi Biopharmaceuticals (NABI) Announces Third Quarter 2012 Financial Results
11/9/2012 10:00:18 AM
More...
|
Nabi Biopharmaceuticals (NABI) Effects Reverse Stock Split and Announces the Completion of and Final Exchange Ratio for the Business Combination Transaction With Biota Holdings Limited (BTA.AX)
11/9/2012 9:51:12 AM
More...
|
Nabi Biopharmaceuticals (NABI) Announces Special Cash Dividend
11/5/2012 9:27:04 AM
More...
|
The Board of Nabi Biopharmaceuticals (NABI) Establishes Ratio for Reverse Stock Split
10/26/2012 6:36:19 AM
More...
|
Nabi Biopharmaceuticals (NABI) Announces Nabi Stockholder Meeting Results and the Approval of the Business Combination Transaction by Biota Holdings Limited (BTA.AX) Stockholders
10/24/2012 8:45:26 AM
More...
|
Biota Holdings Limited (BTA.AX) Announces Approval of Definitive Merger Agreement by Nabi Biopharmaceuticals (NABI) Shareholders
10/23/2012 8:46:40 AM
More...
|
Nabi Biopharmaceuticals (NABI) Announces Exchange Ratio for Proposed Business Combination Transaction With Biota Holdings Limited (BTA.AX)
10/19/2012 8:46:51 AM
More...
|
Nabi Biopharmaceuticals (NABI) Announces Results of NicVAX® Phase II Study in Combination With Varenicline
10/17/2012 9:37:10 AM
More...
|
Two Major Independent Proxy Advisory Firms Recommend Nabi Biopharmaceuticals (NABI) Stockholders Support Amended Transaction With Biota Holdings Limited (BTA.AX) at October 22nd Reconvened Special Meeting
10/16/2012 9:39:17 AM
More...
|
Nabi Biopharmaceuticals (NABI) Announces Adjournment of Special Meeting of Stockholders Until October 22, 2012
9/25/2012 9:36:19 AM
More...
|
|